ATLANTA, July 28 /PRNewswire/ -- Fuqua Enterprises, Inc. (NYSE: FQE)
("Fuqua") today announced operating results for the second quarter ended June
30, 1997.
    Net income for the quarter ended June 30, 1997 was $1,605,000 or $0.36 per
share, on revenues of $62,741,000 compared to $1,838,000 or $.40 per share, on
revenues of $47,495,000 in the second quarter of 1996.
    For the first six months of 1997, net income was $2,947,000 or $.65 per
share, on revenues of $118,412,000 compared to $3,438,000 or $.76 per share,
on revenues of $78,665,000 for the comparable period of 1996.
    Lawrence P. Klamon, President of Fuqua, stated, "The second quarter
operating income from Fuqua's medical products operations increased
substantially due to growth and operational efficiencies achieved at Lumex and
Basic American and the acquisition in February 1997 of Prism Enterprises,
another medical products business.  The results of Fuqua's leather operations
were below those of last year resulting from the liquidation of raw material
hide inventories which were acquired when prices were higher and a temporary
reduction in shipments to a significant customer in the second quarter of
1997.  However, based on current customer orders and more favorable hide
prices, the outlook for the leather operations is for improved results in the
second half."
    Fuqua's medical products operations manufacture a variety of products
including beds, patient aids and mobility products for the acute, long-term
and home health care markets.  Fuqua's leather operations produce a broad line
of leathers that are sold to manufacturers of shoes, handbags, personal
leather goods and furniture in both the U.S. and foreign markets.


                       FUQUA ENTERPRISES, INC.
            (Amounts in thousands, except per share data)

                              For the Three Months      For the Six Months
                                Ended June 30,            Ended June 30,
                              1997           1996      1997          1996
       Revenues:
    Net sales                 $62,708     $46,898    $118,329     $77,398
    Investment income              33         597          83       1,267
    Total revenues             62,741      47,495     118,412      78,665
       Costs and Expenses:
    Cost of sales              49,701      35,312      94,278      60,374
    Selling, general and
     administrative expenses    9,641       8,653      18,014      11,801
    Interest expense              938         761       1,531       1,094
    Total costs and expenses   60,280      44,726     113,823      73,269
    Income before income taxes  2,461       2,769       4,589       5,396
    Income taxes                  856         931       1,642       1,958
    Net income                $ 1,605     $ 1,838     $ 2,947     $ 3,438
       Per share:
    Net income                $  0.36     $  0.40     $  0.65     $  0.76
    Average common shares and
      common share equivalents  4,483       4,603       4,514       4,551

Link to this page: